Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research on the Prophylactic Efficacy of Pancreatic Duct Stenting Combined With Rectal Indomethacin Drug on Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

NCT03643900 is registered in ClinicalTrials.gov with First People's Hospital of Hangzhou as lead sponsor.

NCT NCT03643900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03643900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research on the Prophylactic Efficacy of Pancreatic Duct Stenting Combined With Rectal Indomethacin Drug on Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Lead sponsor
First People's Hospital of Hangzhou
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2018
Completion date
August 18, 2021
Enrollment
618 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, acute necrotizing, post-ercp pancreatitis